Jennifer Doudna

Recipient of the Canada Gairdner International Award, 2016
"for development of CRISPR-CAS as a genome editing tool for eukaryotic cells"

Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences; Professor of Molecular and Cell Biology and Professor of Chemistry at UC Berkeley; Investigator of the Howard Hughes Medical Institute, Berkley, California, USA

Jennifer Doudna is the Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences and she is Professor of Molecular and Cell Biology and Professor of Chemistry at UC Berkeley and an Investigator of the Howard Hughes Medical Institute.  Prof. Doudna’s research seeks to understand how RNA molecules control the expression of genetic information in cells. Her research led to insights about CRISPR-Cas9-mediated bacterial immunity that enabled her lab along with collaborator Emmanuelle Charpentier to harness this system for efficient genome engineering in animals and plants, creating a transformative technology that is revolutionizing the fields of genetics, molecular biology and medicine. She is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine and the National Academy of Inventors. She is also a Fellow of the American Association for the Advancement of Science and the American Society for Microbiology. Dr. Doudna is a recipient of awards including the NSF Waterman Award, the FNIH Lurie Prize, the Paul Janssen Award for Biomedical Research, the Breakthrough Prize in Life Sciences, the Princess of Asturias Award (Spain), the Gruber Prize in Genetics, the Massry Prize and the L’Oreal-UNESCO International Prize for Women in Science. Dr. Doudna has been named as one of Time Magazine’s 100 most influential people in the world (2015) and as one of Foreign Policy’s leading global thinkers (2014). Dr. Doudna is a founder and the executive director of the Innovative Genomics Institute at UC Berkeley and UC San Francisco.

Languages